Globus Medical, Inc.'s stock has surged due to a successful execution of the NuVasive deal and three consecutive guidance hikes, boosting investor confidence and valuation. The $3.1 billion ...

The Globus family of brands has become a Sapphire-level partner to ASTA, marking the supplier's largest investment in the ...

The medical device maker reported big growth in revenue and earnings, driven by strong product sales and a recent major ...

JMP Securities analyst David Turkaly has reiterated their neutral stance on GMED stock, giving a Hold rating on November 11. David Turkaly has ...

Globus Medical (GMED) is one such stock that our proprietary system currently recommends. The company not only has a ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style ...

ICL acquires 110,715 shares in Globus Spirits for ₹9.13 crore, marking entry into spirits industry through investment.

Globus Spirits recorded a revenue of Rs 8741.1 crore, up 18.3 per cent, as compared to Rs 739 crore a year ago.

Globus Medical, Inc. (NYSE: GMED) has unveiled its financial success for the third quarter of 2024, showcasing notable growth ...

Shares of Globus Spirits Ltd declined 11% on November 12 as the spirits firm reported 88% drop in standalone net profit at Rs ...

Shares of Globus Spirits extended its loss to second consecutive day, down over 16 percent to Rs 890 per share on November 13 ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...